Skip to main content

Table 3 Test characteristics of multiple algorithms among patients ≥ 20 y

From: An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance

Algorithms [Pretest prevalence: 0.9%]

TP

TN

FN

FP

Post-test prev.#

Sensitivity [95 CI%]

Specificity [95 CI%]

PPV [95 CI%]

NPV [95 CI%]

1 H ever

15

7429

54

2

0.2%

22 (12–32)

100 (100–100)

88 (73–100)

99 (99–100)

1 H ever OR 1 ER ever

16

7427

53

4

0.3%

23 (13–33)

100 (100–100)

80 (63–98)

99 (99–100)

1 P ever

62

7188

7

243

4.1%

90 (83–97)

97 (96–97)

20 (16–25)

100 (100–100)

1 P ever by a specialist

56

7377

13

54

1.5%

81 (72–90)

99 (99–100)

51 (42–60)

100 (100–100)

2 P by any physician in 1 YR

58

7363

11

68

1.7%

84 (75–93)

99 (99–99)

46 (37–55)

100 (100–100)

2 P by any physician in 2 YR

58

7359

11

72

1.7%

84 (75–93)

99 (99–99)

45 (36–53)

100 (100–100)

2 P by any physician in 3 YR

58

7352

11

79

1.8%

84 (75–93)

99 (99–99)

42 (34–51)

100 (100–100)

3 P by any physician in 1 YR

55

7398

14

33

1.2%

80 (70–89)

100 (99–100)

63 (52–73)

100 (100–100)

3 P by any physician in 2 YR

55

7395

14

54

1.2%

80 (70–89)

100 (99–100)

60 (50–71)

100 (100–100)

3 P by any physician in 3 YR

55

7393

14

38

1.2%

80 (70–89)

100 (99–100)

59 (49–69)

100 (100–100)

2 P with ≥ 1 P by a specialist in 1 YR

54

7404

15

27

1.1%

78 (69–88)

100 (100–100)

67 (56–77)

100 (100–100)

2 P with ≥ 1 P by a specialist in 2 YR

54

7404

15

27

1.1%

78 (69–88)

100 (100–100)

67 (56–77)

100 (100–100)

2 P with ≥ 1 P by a specialist in 3 YR

54

7401

15

30

1.1%

78 (69–88)

100 (100–100)

64 (54–75)

100 (100–100)

3 P with ≥ 1 P by a specialist in 1 YR

53

7419

16

12

0.9%

77 (67–87)

100 (100–100)

82 (72–91)

100 (100–100)

3 P with ≥ 1 P by a specialist in 2 YR

53

7418

16

13

0.9%

77 (67–87)

100 (100–100)

80 (71–90)

100 (100–100)

3 P with ≥ 1 P by a specialist in 3 YR

53

7418

16

13

0.9%

77 (67–87)

100 (100–100)

80 (71–90)

100 (100–100)

(1 H ever) OR (2 P with ≥ 1 P by a specialist in 1 YR)

55

7403

14

28

1.1%

80 (70–89)

100 (100–100)

66 (56–76)

100 (100–100)

(1 H ever) OR (2 P with ≥ 1 P by a specialist in 2 YR)

55

7403

14

28

1.1%

80 (70–89)

100 (100–100)

66 (56–76)

100 (100–100)

(1 H ever) OR (2 P with ≥ 1 P by a specialist in 3 YR)

55

7400

14

31

1.1%

80 (70–89)

100 (99–100)

64 (54–74)

100 (100–100)

(1 H ever) OR (3 P with ≥1 P by a specialist in 1 YR)

54

7417

15

14

0.9%

78 (69–88)

100 (100–100)

79 (70–89)

100 (100–100)

(1 H ever) OR (3 P with ≥1 P by a specialist in 2 YR)

54

7416

15

15

0.9%

78 (69–88)

100 (100–100)

78 (69–88)

100 (100–100)

(1 H ever) OR (3 P with ≥1 P by a specialist in 3 YR)

54

7416

15

15

0.9%

78 (69–88)

100 (100–100)

78 (69–88)

100 (100–100)

(1 H ever) OR (2 P ≥ 8 weeks apart in 2 YR, no exclusions*

57

7378

12

53

1.5%

83 (74–92)

99 (99–100)

52 (43–61)

100 (100–100)

(1 H ever) OR (2 P ≥ 8 weeks apart in 2 YR) excluding Case A or Case B

41

7401

28

30

0.9%

59 (48–71)

100 (100–100)

58 (46–69)

100 (100–100)

(1 H ever) OR (2 P ≥ 8 weeks apart in 3 YR) excluding Case A or Case B

41

7396

28

35

1.0%

59 (48–71)

100 (99–100)

54 (43–65)

100 (100–100)

(1 H ever) OR (2 P ≥ 8 weeks apart in 4 YR) excluding Case A or Case B

43

7394

26

37

1.1%

62 (51–74)

100 (99–100)

54 (43–65)

100 (100–100)

(1 H ever) OR (2 P ≥ 8 weeks apart in 5 YR) excluding Case A or Case B

44

7390

25

41

1.1%

64 (52–75)

99 (99–100)

52 (41–62)

100 (100–100)

(1 H ever) OR (2 P ≥ 8 weeks apart in 2 YR) excluding Case A

41

7402

28

29

0.9%

59 (48–71)

100 (100–100)

59 (47–70)

100 (100–100)

  1. All Ages: N = 7500 patients (69 RA and 7431 non-RA); # = Post-test prevalence; TP = True Positive; TN = True Negative; FN = False Negative; FP = False Positive
  2. H: Hospitalization diagnosis code; P = physician diagnosis code; Specialist = rheumatologist, internal medicine, orthopedic surgeon; *Exclusions: Case A: Patients with ≥ 2 P with another rheumatology diagnosis subsequent to an RA diagnosis OR Case B: Patients for which the diagnosis of RA was not confirmed by a specialist. Other rheumatology diagnoses include: Osteoarthritis (715), Gout (274, 712), Polymyalgia Rheumatica (725), other seronegative spondyloarthropathy (721), Ankylosing spondylitis (720), psoriasis (696), synovitis/tenosynovitis/bursitis (727), connective tissue disorder (710), vasculitis (446), others (716; 718; 728; 727; 728; 729; 781).